Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer (Q34563208)

3 August 2017

title

Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer (English)

1 reference

3 August 2017

1 reference

12

Elai Davicioni

1 reference

3 August 2017

4

Nicholas Erho

1 reference

3 August 2017

14

Peter C Black

1 reference

3 August 2017

Anirban P Mitra

1

1 reference

3 August 2017

Lucia L Lam

2

1 reference

3 August 2017

Mercedeh Ghadessi

3

1 reference

3 August 2017

Ismael A Vergara

5

1 reference

3 August 2017

Mohammed Alshalalfa

6

1 reference

3 August 2017

Christine Buerki

7

1 reference

3 August 2017

Zaid Haddad

8

1 reference

3 August 2017

Thomas Sierocinski

9

1 reference

3 August 2017

Timothy J Triche

10

1 reference

3 August 2017

Eila C Skinner

11

1 reference

3 August 2017

Siamak Daneshmand

13

1 reference

3 August 2017

language of work or name

English

0 references

publication date

24 October 2014

1 reference

Journal of the National Cancer Institute

3 August 2017

published in

1 reference

3 August 2017

volume

106

1 reference

3 August 2017

issue

11

1 reference

Comprehensive molecular characterization of urothelial bladder carcinoma

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Construction of human activity-based phosphorylation networks.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

An integrated encyclopedia of DNA elements in the human genome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

A central role for long non-coding RNA in cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

The human phosphotyrosine signaling network: evolution and hotspots of hijacking in cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

A four-gene signature predicts disease progression in muscle invasive bladder cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

7 July 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Enrichment map: a network-based method for gene-set enrichment visualization and interpretation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Strategies for molecular expression profiling in bladder cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Generation of a concise gene panel for outcome prediction in urinary bladder cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Molecular pathogenesis and diagnostics of bladder cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

A map of human cancer signaling

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Molecular markers for bladder cancer: the road to a multimarker approach

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

An annotation infrastructure for the analysis and interpretation of Affymetrix exon array data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Bladder cancer outcome and subtype classification by gene expression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241889

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU290

Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU290

Predictors of cancer-specific mortality after disease recurrence following radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU290

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU290

Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU290

Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU290

Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer

21 January 2018

1 reference

12 December 2020

Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update

1 reference

12 December 2020

Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder

1 reference

12 December 2020

Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium

1 reference

12 December 2020

Regulatory network motifs and hotspots of cancer genes in a mammalian cellular signalling network

1 reference

12 December 2020

Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJU290

1 reference

3 August 2017

1 reference

3 August 2017

1 reference